CLOAD; Sharon T.
Patent Applications and Registrations
Patent applications and USPTO patent grants for CLOAD; Sharon T..The latest application filed is for "fibronectin based scaffold domain proteins that bind pcsk9".
- CLOAD; Sharon T. - Cambridge MA
| Patent | Date |
|---|---|
| Fibronectin Based Scaffold Domain Proteins That Bind Pcsk9 App 20210277089 - CAMPHAUSEN; Ray ; et al. | 2021-09-09 |
| Fibronectin based scaffold domain proteins that bind PCSK9 Grant 10,947,297 - Camphausen , et al. March 16, 2 | 2021-03-16 |
| Serum albumin binding molecules Grant 10,934,572 - Gosselin , et al. March 2, 2 | 2021-03-02 |
| Serum Albumin Binding Molecules App 20190203248 - GOSSELIN; Michael L. ; et al. | 2019-07-04 |
| Serum albumin binding molecules Grant 10,221,438 - Gosselin , et al. | 2019-03-05 |
| Fibronectin Based Scaffold Domain Proteins That Bind Pcsk9 App 20180201665 - Camphausen; Ray ; et al. | 2018-07-19 |
| Fibronectin based scaffold domain proteins that bind PCSK9 Grant 9,856,309 - Camphausen , et al. January 2, 2 | 2018-01-02 |
| Serum Albumin Binding Molecules App 20170145464 - GOSSELIN; Michael L. ; et al. | 2017-05-25 |
| Serum albumin binding molecules Grant 9,540,424 - Gosselin , et al. January 10, 2 | 2017-01-10 |
| Fibronectin Based Scaffold Domain Proteins That Bind Pcsk9 App 20160159883 - Camphausen; Ray ; et al. | 2016-06-09 |
| Fibronectin based scaffold domain proteins that bind PCSK9 Grant 9,234,027 - Camphausen , et al. January 12, 2 | 2016-01-12 |
| Serum Albumin Binding Molecules App 20150152147 - GOSSELIN; Michael L. ; et al. | 2015-06-04 |
| Serum albumin binding molecules Grant 8,969,289 - Gosselin , et al. March 3, 2 | 2015-03-03 |
| Fibronectin Based Scaffold Domain Proteins That Bind Pcsk9 App 20130210703 - Camphausen; Ray ; et al. | 2013-08-15 |
| Fibronectin based scaffold domain proteins that bind to PCSK9 Grant 8,420,098 - Camphausen , et al. April 16, 2 | 2013-04-16 |
| Fibronectin Based Scaffold Domain Proteins That Bind To Pcsk9 App 20120094909 - Camphausen; Ray ; et al. | 2012-04-19 |
| Serum Albumin Binding Molecules App 20110305663 - Gosselin; Michael L. ; et al. | 2011-12-15 |
| Regulatable, catalytically active nucleic acids App 20040126882 - Ellington, Andrew D. ; et al. | 2004-07-01 |
| Compositions selective for adenosine diphosphate and methods of using same App 20040018515 - Diener, John L. ; et al. | 2004-01-29 |
| Compositions selective for caffeine or aspartame and methods of using same App 20030228603 - Cload, Sharon T. ; et al. | 2003-12-11 |
| Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acids App 20030152992 - Laing, Lance G. ; et al. | 2003-08-14 |
| Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acids Grant 6,569,628 - Laing , et al. May 27, 2 | 2003-05-27 |
| Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acids App 20020031778 - Laing, Lance G. ; et al. | 2002-03-14 |
| Triazine antiviral compounds Grant 6,335,339 - Arenas , et al. January 1, 2 | 2002-01-01 |
| Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acids Grant 6,331,392 - Laing , et al. December 18, 2 | 2001-12-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 